BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29582400)

  • 1. Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons.
    Lopez JR; Uryash A; Kolster J; Estève E; Zhang R; Adams JA
    Mol Neurobiol; 2018 Nov; 55(11):8680-8694. PubMed ID: 29582400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
    Lopez JR; Kolster J; Zhang R; Adams J
    J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice.
    Altamirano F; Perez CF; Liu M; Widrick J; Barton ER; Allen PD; Adams JA; Lopez JR
    PLoS One; 2014; 9(9):e106590. PubMed ID: 25181488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of Intracellular Ca
    Lopez JR; Kolster J; Uryash A; Estève E; Altamirano F; Adams JA
    Mol Neurobiol; 2018 Jan; 55(1):603-618. PubMed ID: 27975174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective Effect of Whole Body Periodic Acceleration in Dystrophic Phenotype
    Uryash A; Mijares A; Esteve E; Adams JA; Lopez JR
    Front Physiol; 2021; 12():658042. PubMed ID: 34017265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant Properties of Whole Body Periodic Acceleration (pGz).
    Uryash A; Bassuk J; Kurlansky P; Altamirano F; Lopez JR; Adams JA
    PLoS One; 2015; 10(7):e0131392. PubMed ID: 26133377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological basis of neuroprotection and neurotherapeutic effects of Whole Body Periodic Acceleration (pGz).
    Adams JA; Uryash A; Bassuk J; Sackner MA; Kurlansky P
    Med Hypotheses; 2014 Jun; 82(6):681-7. PubMed ID: 24661939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase.
    Chao DS; Silvagno F; Bredt DS
    J Neurochem; 1998 Aug; 71(2):784-9. PubMed ID: 9681470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
    Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
    FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil, a Nitric Oxide Donor and ATP-Sensitive Potassium Channel Opener, Protects Against Dystrophin-Deficient Cardiomyopathy.
    Afzal MZ; Reiter M; Gastonguay C; McGivern JV; Guan X; Ge ZD; Mack DL; Childers MK; Ebert AD; Strande JL
    J Cardiovasc Pharmacol Ther; 2016 Nov; 21(6):549-562. PubMed ID: 26940570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mdx muscle pathology is independent of nNOS perturbation.
    Crosbie RH; Straub V; Yun HY; Lee JC; Rafael JA; Chamberlain JS; Dawson VL; Dawson TM; Campbell KP
    Hum Mol Genet; 1998 May; 7(5):823-9. PubMed ID: 9536086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
    Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
    J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential vulnerability of immature murine neurons to oxygen-glucose deprivation.
    Jiang X; Mu D; Manabat C; Koshy AA; Christen S; Täuber MG; Vexler ZS; Ferriero DM
    Exp Neurol; 2004 Nov; 190(1):224-32. PubMed ID: 15473995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periodic acceleration (pGz) prior to whole body ischemia reperfusion injury provides early cardioprotective preconditioning.
    Adams JA; Wu H; Bassuk JA; Arias J; Uryash A; Jorapur V; Lamas GA; Kurlansky P
    Life Sci; 2010 May; 86(19-20):707-15. PubMed ID: 20211190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing Muscle Intracellular Ca
    Uryash A; Umlas J; Mijares A; Adams JA; Lopez JR
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37892970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.
    Pritchard HAT; Pires PW; Yamasaki E; Thakore P; Earley S
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9745-E9752. PubMed ID: 30181262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
    Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole body periodic acceleration (pGz) improves endotoxin induced cardiomyocyte contractile dysfunction and attenuates the inflammatory response in mice.
    Adams JA; Lopez JR; Uryash A; Sackner MA
    Heliyon; 2021 Mar; 7(3):e06444. PubMed ID: 33748496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional activity and expression of inducible nitric oxide synthase (iNOS) in muscle of the isolated distal colon of mdx mice.
    Vannucchi MG; Corsani L; Azzena GB; Faussone-Pellegrini MS; Mancinelli R
    Muscle Nerve; 2004 Jun; 29(6):795-803. PubMed ID: 15170612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Body Periodic Acceleration Improves Muscle Recovery after Eccentric Exercise.
    López JR; Mijares A; Kolster J; Henríquez-Olguín C; Zhang R; Altamirano F; Adams JA
    Med Sci Sports Exerc; 2016 Aug; 48(8):1485-94. PubMed ID: 27031739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.